Literature DB >> 3053764

Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.

L P Perera1, L R Marques, A D O'Brien.   

Abstract

The major obstacle in large-scale epidemiological investigations of the incidence of Shiga-like toxin (SLT)-producing Escherichia coli in diarrheal stools is the lack of a rapid, specific test to detect toxin. Enterohemorrhagic E. coli produces elevated levels of SLT-I, SLT-II, or both cytotoxins (also called Verotoxins). SLT-I but not SLT-II can be neutralized by antiserum to purified Shiga toxin and by monoclonal antibodies to the B subunit of SLT-I. In this study, monoclonal antibodies were generated against a crude preparation of SLT-II produced by an E. coli K-12 strain lysogenized with the 933W toxin-converting phage of enterohemorrhagic E. coli 933. Hybridoma culture supernatants were screened for anti-SLT-II antibodies by a cytotoxicity neutralization assay and by an enzyme-linked immunosorbent assay (ELISA). Of 53 ELISA-positive lines, 5 were capable of neutralizing the cytotoxicity of SLT-II but not of SLT-I, Shiga toxin, or a variant of SLT-II produced by E. coli that causes edema disease of swine. All five monoclonal antibodies immunoprecipitated the isolated A subunit of SLT-II but not the B subunit. Of these five neutralizing monoclonal antibodies, four were of the immunoglobulin M class and one belonged to the immunoglobulin G1 subclass. All five lines had kappa light chains. These neutralizing monoclonal antibodies have been used as probes in a colony ELISA to detect SLT-II-positive bacterial colonies. The colony ELISA with these monoclonal antibodies is a specific, sensitive test with potential diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053764      PMCID: PMC266830          DOI: 10.1128/jcm.26.10.2127-2131.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli.

Authors:  M P Jackson; J W Newland; R K Holmes; A D O'Brien
Journal:  Microb Pathog       Date:  1987-02       Impact factor: 3.738

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

4.  Detection of Vero cytotoxic strains of Escherichia coli isolated from diseased animals.

Authors:  M Kashiwazaki; T Ogawa; Y Isayama; Y Akaike; K Tamura; R Sakazaki
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1980

5.  Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.

Authors:  J E Brown; D E Griffin; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Characterization of monoclonal antibodies that react with unique and cross-reacting determinants of cholera enterotoxin and its subunits.

Authors:  R K Holmes; E M Twiddy
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.

Authors:  A D O'Brien; G D LaVeck; D E Griffin; M R Thompson
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

8.  Cell membrane antigen isolation with the staphylococcal protein A-antibody adsorbent.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Subunit structure of Shigella cytotoxin.

Authors:  S Olsnes; R Reisbig; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  57 in total

1.  Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.

Authors:  Cory M Robinson; James F Sinclair; Michael J Smith; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

2.  Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.

Authors:  Tiffany R Keepers; Lisa K Gross; Tom G Obrig
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Monoclonal antibody 11E10, which neutralizes shiga toxin type 2 (Stx2), recognizes three regions on the Stx2 A subunit, blocks the enzymatic action of the toxin in vitro, and alters the overall cellular distribution of the toxin.

Authors:  Michael J Smith; Angela R Melton-Celsa; James F Sinclair; Humberto M Carvalho; Cory M Robinson; Alison D O'Brien
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

4.  Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.

Authors:  L P Perera; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

Review 5.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Shiga toxin-producing Escherichia coli-associated kidney failure in a 40-year-old patient and late diagnosis by novel bacteriologic and toxin detection methods.

Authors:  Louise D Teel; Brett R Steinberg; Naomi E Aronson; Alison D O'Brien
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli.

Authors:  H Karch; T Meyer
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.

Authors:  S Ashkenazi; T G Cleary
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Production and characterization of protective human antibodies against Shiga toxin 1.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.